[1] Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist, 2010, 15(6): 556- 565.[2] Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 2001, 414(6865): 799-806.[3] Sakaue H, Ogawa W, Matsumoto M, Kuroda S, Takata M, Sugimoto T, Spiegelman BM, Kasuga M. Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3 -kinase. J Biol Chem, 1998, 273 (44): 28945-28952.[4] Cross MJ, Stewart A, Hodgkin MN, Kerr DJ, Wakelam MJO. Wortmannin and its structural analogue demethoxyviridin inhibit stimulated phospholipase A2 activity in Swiss 3T3 cells. J Biol Chem, 1995, 270(43): 25352- 25355.[5] Tomiyama K, Nakata H, Sasa H, Arimura S, Nishio E, Watanabe Y. Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells. Biochem Biophys Res Commun, 1995, 212(1): 263-269.[6] Xia X, Serrero G. Inhibition of adipose differentiation by phosphatidylinositol 3-kinase inhibitors. J Cell Physiol, 1999, 178(1): 9-16.[7] Aubin D, Gagnon A, Sorisky A. Phosphoinositide 3-kinase is required for human adipocyte differentiation in culture. Int J Obesity, 2005, 29(8): 1006-1009.[8] Cantley LC. The phosphoinositide 3-kinase pathway. Science, 2002, 296(5573): 1655-1657.[9] 王晓南, 吴青, 张连生, 吴一品, 舒砚文. PI3K/Akt抑制剂渥曼青霉素对白血病细胞增殖和凋亡的影响. 中国肿瘤生物治疗杂志, 2010, 17(1): 82-87.[10] 石丹, 范德生, 甄蕾, 张红. PI3K/Akt信号通路抑制剂在舌鳞癌细胞系增殖和凋亡中的作用. 口腔颌面 外科杂志, 2010, 20(5): 324-326.[11] Ihle NT, Lemos R Jr, Wipf P, Yacoub A, Mitchell C, Siwak D, Mills GB, Dent P, Kirkpatrick DL, Powis G. Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic ras is a dominant predictor for resistance. Cancer Res, 2009, 69(1): 143-150.[12] Varticovski L, Lu ZR, Mitchell K, de Aos I, Kopecek J. Water-soluble HPMA copolymer- wortmannin conjugate retains phosphoinositide 3-kinase inhibitory activity in vitro and in vivo. J Controlled Rel, 2001, 74(1-3): 275-281.[13] Nobusue H, Kano K. Establishment and characteristics of porcine preadipocyte cell lines derived from mature adipocytes. J Cell Biochem, 2010, 109(3): 542-552.[14] 王丽, 那威, 王宇祥, 王彦博, 王宁, 王启贵, 李玉茂, 李辉. 鸡PPARγ基因的表达特性及其对脂肪细 胞增殖分化的影响. 遗传, 2012, 34(5): 454-464.[15] 谢霞, 高青, 王艳丽, 田翀. 抑制PI3K/PKB信号通路提高胃癌细胞化疗敏感性的研究. 中国药理学通报 , 2008, 24(12): 1666-1670.[16] Arcaro A, Wymann MP. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochemical J, 1993, 296(Pt2): 297-301.[17] Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, Nonomura Y, Matsuda Y. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3- kinase in RBL-2H3 cells. J Biol Chem, 1993, 268(34): 25846-25856.[18] Prevo R, Deutsch E, Sampson O, Diplexcito J, Cengel K, Harper J, O'Neill P, McKenna WG, Patel S, Bernhard EJ. Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI -103 enhances tumor radiosensitivity. Cancer Res, 2008, 68(14): 5915-5923. |